The innovative program harnesses GATC's AI-powered platform to rapidly de-risk and optimize drug discovery and development, accelerating the transition to clinical trials.

该创新项目利用GATC的人工智能平台，快速降低风险，优化药物发现和开发，加速向临床试验的过渡。

MORGANTOWN, W.Va.

弗吉尼亚州摩根敦。

,

,

Jan. 28, 2025

2025年1月28日

/PRNewswire/ -- West

/PRNewswire/--西部

Virginia University

弗吉尼亚大学

(

(

WVU

WVU 的

), one of the top public research institutions in the nation, has formed a strategic partnership with GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery. The collaborative agreement facilitates the combination of

)美国顶级公共研究机构之一的GATC Health Corp与GATC Health Corp建立了战略合作伙伴关系，GATC Health Corp是一家领先的科技生物公司，利用人工智能（AI）来改变药物发现。合作协议有助于

WVU's

WVU的

early-stage drug research and GATC's AI drug discovery platform to accelerate commercialization and create de-risked bio-tech investment opportunities.

早期药物研究和GATC的AI药物发现平台，以加速商业化并创造无风险的生物技术投资机会。

Continue Reading

继续阅读

The program aims to de-risk and accelerate the commercialization of groundbreaking research conducted at

该计划旨在降低风险并加速在

WVU

WVU 的

. Utilizing GATC Health's Multiomics Advanced Technology™ (MAT) AI, which simulates complex systems biology with approximately 90% accuracy, the program empowers researchers to simulate billions of biological interactions, enabling rapid, accurate target discovery, drug identification, and testing at the earliest stages of drug development.

该程序利用GATC Health公司的Multiomics Advanced Technology™（MAT）AI模拟复杂系统生物学，准确率约为90%，使研究人员能够模拟数十亿种生物相互作用，从而在药物开发的最早阶段实现快速，准确的目标发现，药物鉴定和测试。

By predicting safety, efficacy, and off-target effects, GATC's platform reduces the risk, time, and cost of traditional drug discovery while simulating clinical trial outcomes before laboratory work begins. GATC's technology has contributed to significant discoveries in addiction, PTSD, diabetes, obesity, glioblastoma, and cognitive decline..

通过预测安全性，有效性和脱靶效应，GATC的平台降低了传统药物发现的风险，时间和成本，同时在实验室工作开始之前模拟临床试验结果。GATC的技术为成瘾、创伤后应激障碍、糖尿病、肥胖、胶质母细胞瘤和认知能力下降等方面的重大发现做出了贡献。。

Innovative program harnesses GATC's AI-powered platform to rapidly de-risk and optimize drug discovery and development.

创新计划利用GATC的人工智能平台快速降低风险并优化药物发现和开发。

Post this

发布此

The partnership not only advances academic research but also creates compelling investment opportunities by significantly reducing the risks traditionally associated with biopharma ventures. By leveraging GATC Health's AI, the program identifies high-potential projects early in the drug development process.

这种伙伴关系不仅推进了学术研究，而且通过显着降低传统上与生物制药企业相关的风险，创造了引人注目的投资机会。通过利用GATC Health的AI，该计划在药物开发过程的早期确定了高潜力的项目。

This precision enables faster decision-making while de-risking university research as it progresses toward pre-clinical work, IND-enabling studies, and clinical trials. As the exclusive AI partner with Lloyd's of .

随着大学研究朝着临床前工作，IND支持研究和临床试验的方向发展，这种精确度可以更快地做出决策，同时降低大学研究的风险。作为劳埃德的独家AI合作伙伴。

London

伦敦

syndicate Medical & Commercial International and in partnership with Acrisure Re Corporate Advisory & Solutions, the international financing and consulting firm responsible for program sales and distribution, GATC is supporting the underwriting of the first insurance-backed financial program to fund clinical trials, offering a secure and innovative funding source for joint ventures stemming from .

辛迪加医疗与商业国际公司（syndicate Medical&Commercial International）与负责项目销售和分销的国际融资和咨询公司Acrisure Re Corporate Advisory&Solutions合作，GATC正在支持承保首个保险支持的金融项目，为临床试验提供资金，为源自的合资企业提供安全而创新的资金来源。

WVU

WVU 的

and GATC collaborations.

和GATC合作。

'This partnership highlights

“这一合作关系突出了

West Virginia University's

dedication to driving innovation and transforming lives through groundbreaking research,' said Dr.

博士说，致力于通过开创性的研究推动创新和改变生活。

Clay Marsh

粘土沼泽

, Chancellor & Executive Dean for Health Sciences at

，校长兼健康科学执行院长

West Virginia University

西弗吉尼亚大学

. 'By joining forces with GATC Health and utilizing their cutting-edge AI technology, we are empowering our researchers to accelerate the path from academic discovery to life-changing therapies, ensuring

“通过与GATC Health联手并利用其尖端的人工智能技术，我们正在授权我们的研究人员加速从学术发现到改变生活疗法的道路，确保

WVU

WVU 的

remains at the forefront of addressing critical healthcare challenges and delivering meaningful outcomes that benefit patients in

在应对关键的医疗保健挑战和提供有益于患者的有意义的结果方面仍然处于领先地位

West Virginia

西弗吉尼亚州

and across the globe.'

以及全球各地。”

Traditional drug discovery and development is a notoriously risky, expensive, and time-consuming process, often requiring over a decade and billions of dollars to bring a single therapy to market. The high failure rate—nearly 90% of drug candidates fail during clinical trials—stems from challenges such as inaccurate target identification, unforeseen toxicity, poor efficacy, and lengthy preclinical and clinical trial processes.

。高失败率近90%的候选药物在临床试验中失败是由于诸如目标识别不准确，不可预见的毒性，疗效差以及漫长的临床前和临床试验过程等挑战。

By applying GATC Health's AI across these critical stages, drug discovery is becoming faster, more efficient, and more likely to succeed..

通过在这些关键阶段应用GATC Health的AI，药物发现变得更快，更有效，更可能成功。。

'We are thrilled to partner with

“我们很高兴与

WVU

WVU

and launch our University Research Accelerator Program,' said

并启动我们的大学研究加速器项目

Tyrone Lam

Tyrone Lam

, Chief Business Officer of GATC Health Corp. 'This collaboration highlights our commitment to empowering academic institutions with cutting-edge AI tools that bridge the gap between research and commercialization, enabling faster delivery of life-changing therapies.'

GATC Health Corp.首席商务官表示：“这项合作突显了我们致力于为学术机构提供尖端人工智能工具，以弥合研究与商业化之间的差距，从而更快地提供改变生命的疗法。”

By focusing on high-probability projects and leveraging GATC's 'fast-fail' AI analysis,

通过专注于高概率项目并利用GATC的“快速失败”AI分析，

WVU

WVU 的

will not only enhance its research capacity but also generate revenue much earlier in the discovery process. This innovative approach establishes

不仅可以提高其研究能力，而且可以在发现过程中更早地产生收入。这种创新方法建立了

WVU

WVU 的

as a leader in AI-driven research commercialization.

作为人工智能驱动的研究商业化的领导者。

GATC West Virginia, a subsidiary of GATC Health, is enhancing its AI-powered lab operations within the WVU Innovation Building, strategically located near

GATC West Virginia是GATC Health的子公司，正在WVU创新大楼内加强其人工智能实验室运营，该大楼位于战略附近

West Virginia University's

西弗吉尼亚大学

campus. The state-of-the-art lab facilitates rapid iteration between GATC's MAT AI and traditional lab experiments. Currently, it is focused on synthesizing drug compounds, a critical step in advancing preclinical testing for innovative treatments targeting conditions such as opioid use disorder, polysubstance use disorder, post-traumatic stress disorder, anxiety, diabetes, glioblastoma, Alzheimer's and more.

。最先进的实验室有助于GATC的MAT AI和传统实验室实验之间的快速迭代。目前，它专注于合成药物化合物，这是推进针对阿片类药物使用障碍，多物质使用障碍，创伤后应激障碍，焦虑症，糖尿病，胶质母细胞瘤，阿尔茨海默病等疾病的创新治疗的临床前测试的关键步骤。

To support this growth, GATC West Virginia is expanding its preclinical capabilities by hiring additional scientists this year, reinforcing its commitment to innovation and scientific excellence..

。。

About

关于

West Virginia University

西弗吉尼亚大学

West Virginia University

西弗吉尼亚大学

, located in

，位于

Morgantown, WV

西弗吉尼亚州摩根敦

, is a leading public research institution dedicated to creating solutions that address the challenges of today and tomorrow. Through its world-class faculty and innovative research initiatives,

是一家领先的公共研究机构，致力于创建解决方案，以应对当今和未来的挑战。通过其世界一流的师资队伍和创新的研究计划，

WVU

WVU

is driving advancements across a wide range of disciplines.

正在推动广泛学科的进步。

About GATC Health Corp

关于GATC Health Corp

GATC Health Corp is a technology company revolutionizing drug discovery and development through its transformative AI platform and approach. The company's validated and proprietary Multiomics Advanced Technology™ (MAT) simulates human biochemistry's billions of interactions to rapidly create novel therapeutics, identify and confirm targets, accelerate development, and de-risk drug pipelines by predicting efficacy, safety, and off-target effects.

GATC Health Corp是一家技术公司，通过其变革性的AI平台和方法，彻底改变了药物的发现和开发。该公司经验证且专有的Multiomics Advanced Technology™（MAT）模拟人类生物化学的数十亿次相互作用，通过预测疗效，安全性和脱靶效应，快速创建新疗法，识别和确认靶标，加速开发和降低药物管道风险。

For more information, visit .

有关更多信息，请访问。

www.gatchealth.com

www.gatchealth.com

.

.

SOURCE GATC Health Corp

来源GATC Health Corp

WANT YOUR COMPANY'S NEWS

想要你公司的新闻

FEATURED ON PRNEWSWIRE.COM?

PRNEWSWIRE的特色节目。COM？

440k+

44万+

Newsrooms &

新闻编辑室&

Influencers

影响者

9k+

9千+

Digital Media

数字媒体

Outlets

出口

270k+

27万+

Journalists

记者

Opted In

选择加入

GET STARTED

快速入门